Gene transfer into rabbit arteries with adeno‐associated virus and adenovirus vectors
- 20 February 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (5) , 545-554
Abstract
Background: Gene transfer offers considerable potential for altering vessel wall physiology and intervention in vascular disease. Therefore, there is great interest in developing optimal strategies and vectors for efficient, targeted gene delivery into a vessel wall.Methods: We studied adeno‐associated viruses (AAV; 9 × 108 to 4 × 109 TU/ml) for their usefulness to transduce rabbit arteries in vivo in comparison with adenoviruses (Adv; 1 × 109 to 1 × 1010 pfu/ml). 100 µl of viruses or placebo solution were injected intraluminally into transiently isolated carotid segments.Results: In normal arteries AAV transduced mainly medial smooth muscle cells (SMC) while Adv transduced exclusively endothelial cells (EC). Mechanical injury to EC layer and internal elastic lamina enabled Adv to penetrate and transduce medial SMC. Transgene expression in EC after the AAV‐mediated gene transfer was very low. The use of the EC‐specific Tie‐1 promoter did not lead to specific transgene expression in EC. Transgene expression in SMC persisted for at least 100 days after the AAV treatment whereas the Adv‐mediated effect diminished in 14 days. AAV caused only a modest increase in EC VCAM‐1 expression and proliferation rate of vascular cells as compared with the mock‐treated arteries while Adv caused an extensive inflammatory cell infiltration, VCAM‐1 expression, vascular cell proliferation and morphological damages.Conclusions: Significant differences were observed between the AAV and the Adv vectors in their patterns of arterial transduction and consequent inflammatory responses. These distinct properties may be utilized for different applications in vascular biology research and gene therapy for cardiovascular diseases. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Cell-Type-Specific Characteristics Modulate the Transduction Efficiency of Adeno-Associated Virus Type 2 and Restrain Infection of Endothelial CellsJournal of Virology, 2002
- Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus VectorsJournal of Virology, 2002
- Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial CellsMolecular Therapy, 2001
- Novel Tools for Production and Purification of Recombinant Adenoassociated Virus VectorsHuman Gene Therapy, 1998
- β -Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and AdenovirusesHuman Gene Therapy, 1998
- Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg IschemiaHuman Gene Therapy, 1998
- Adeno-associated virus-mediated gene transfer into rat carotid arteriesGene Therapy, 1997
- Gene therapy for vascular diseasesAtherosclerosis, 1995
- Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia.Journal of Clinical Investigation, 1995
- Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994